Related Experiment Video
Updated: Jan 28, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Combining stereotactic body radiation therapy with immunotherapy: current data and future directions
Alexander J Lin1, Michael Roach1, Jeffrey Bradley1
1Department of Radiation Oncology, Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA.
Stereotactic body radiation therapy (SBRT) shows promise for early-stage non-small cell lung cancer (NSCLC). Combining SBRT with immunotherapy may improve outcomes by addressing disease progression and potentially triggering the abscopal effect.
Area of Science:
- Oncology
- Radiation Oncology
- Immunology
Background:
- Stereotactic body radiation therapy (SBRT) provides excellent local control for early-stage non-small cell lung cancer (NSCLC).
- A significant need exists for tolerable systemic therapies to manage regional and distant disease progression in NSCLC.
- Immunotherapy has demonstrated potential for sustained disease control in a subset of patients with metastatic NSCLC.
Purpose of the Study:
- To review the current data on the synergy between radiation and immunotherapy in NSCLC.
- To highlight recent clinical trial updates in the rapidly evolving field of immuno-radiation therapy.
- To explore the potential of immunotherapy as a systemic treatment to complement SBRT for NSCLC.
Main Methods:
- Review of current scientific literature and clinical trial data.
- Analysis of evidence supporting the combination of radiation therapy and immunotherapy.
- Focus on recent advancements and ongoing research in immuno-radiation therapy for NSCLC.
Main Results:
- Growing evidence suggests a clinical synergy between radiation and immunotherapy.
- Several ongoing clinical trials are investigating the abscopal effect in the context of immuno-radiation therapy.
- Immunotherapy shows promise for sustained disease control in a subset of metastatic NSCLC patients.
Conclusions:
- The combination of SBRT and immunotherapy is a promising strategy for NSCLC management.
- Further research and clinical trials are crucial to optimize immuno-radiation therapy protocols.
- Understanding the abscopal effect may unlock new therapeutic avenues for NSCLC.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Biological Effects of Radiation
Tumor Immunotherapy
Gene Therapy
Radiation: Applications
The average...
Absorption of Radiation

